Recent Finacing
Recent Raise
GyreOx's MACRO platform generates automated gyrocycles—modified macrocyclic peptides combining biologic-like targeting with small-molecule cell entry—to address intracellular protein–protein interactions in cancer, inflammation, and autoimmune diseases.
Focus Areas
Recent Investors
Funding round
Investors